Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Raised to $232 at Jefferies

April 30, 2026 1:31 PM
Jefferies analyst Akash Tewar raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $232.00 (from $225.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change